Patents by Inventor David O'Regan

David O'Regan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230386636
    Abstract: A computer implemented method for supporting the treatment of insomnia with melatonin. The method includes receiving sleep data relating to a patient; determining a dosage time for the patient to take a dose of the melatonin based on the sleep data; and indicating the dosage time.
    Type: Application
    Filed: May 3, 2023
    Publication date: November 30, 2023
    Applicant: Closed Loop Medicine Ltd.
    Inventors: Paul Goldsmith, Adrian Williams, David O'Regan, David Cox
  • Publication number: 20230317230
    Abstract: A method for treating obesity in a patient, the method comprising administering a dose of a GLP1 agonist to the patient in a treatment regimen effective to manage the patient's satiety and thereby effect a reduction in the patient's weight; and, in conjunction with the administration of the dose of GLP1 agonist, engaging in a directed digital therapeutic program that manages patient weight loss and the treatment regimen for the GLP1 agonist with the objective of achieving a predetermined target weight for the patient, wherein the patient achieves the target weight.
    Type: Application
    Filed: June 5, 2023
    Publication date: October 5, 2023
    Inventors: Felicity Kate SARTAIN, David COX, Paul GOLDSMITH, Hakim Adam YADI, Andrew John McGlashan RICHARDS, David O'REGAN, Bruce CAMPBELL, Michael CATT
  • Patent number: 11710547
    Abstract: The present disclosure relates to methods and systems suitable for use in identifying and providing personalised medicine to a patient. In some aspects, systems and method generate a co-therapy regimen for a patient suffering from a disease or condition. An identification of a co-therapy suitable to treat the disease or condition is received. A desired patient endpoint and a patient position are received, wherein the patient position is defined relative to the desired patient endpoint. A dataset relating to the patient is stored. The dataset comprises one or more patient data based on patient-related measurements. The dataset, the patient position and the desired patient endpoint are processed to generate a regimen for the co-therapy. The regimen is stored in a database.
    Type: Grant
    Filed: April 28, 2020
    Date of Patent: July 25, 2023
    Assignee: CLOSED LOOP MEDICINE LTD.
    Inventors: Paul Goldsmith, Hakim Adam Yadi, Andrew John McGlashan Richards, Felicity Kate Sartain, David Cox, David O'Regan
  • Publication number: 20220328191
    Abstract: The present disclosure relates to methods and systems suitable for use in identifying and providing personalised medicine to a patient. In some aspects, systems and method generate a co-therapy regimen for a patient suffering from a disease or condition. An identification of a co-therapy suitable to treat the disease or condition is received. A desired patient endpoint and a patient position are received, wherein the patient position is defined relative to the desired patient endpoint. A dataset relating to the patient is stored. The dataset comprises one or more patient data based on patient-related measurements. The dataset, the patient position and the desired patient endpoint are processed to generate a regimen for the co-therapy. The regimen is stored in a database.
    Type: Application
    Filed: June 28, 2022
    Publication date: October 13, 2022
    Applicant: Closed Loop Medicine Ltd.
    Inventors: Paul Goldsmith, Hakim Adam Yadi, Andrew John McGlashan Richards, Felicity Kate Sartain, David Tonatiuh Cox, David O'Regan
  • Publication number: 20200350073
    Abstract: The present disclosure relates to methods and systems suitable for use in identifying and providing personalised medicine to a patient. In some aspects, systems and method generate a co-therapy regimen for a patient suffering from a disease or condition. An identification of a co-therapy suitable to treat the disease or condition is received. A desired patient endpoint and a patient position are received, wherein the patient position is defined relative to the desired patient endpoint. A dataset relating to the patient is stored. The dataset comprises one or more patient data based on patient-related measurements. The dataset, the patient position and the desired patient endpoint are processed to generate a regimen for the co-therapy. The regimen is stored in a database.
    Type: Application
    Filed: April 28, 2020
    Publication date: November 5, 2020
    Applicant: Closed Loop Medicine Ltd.
    Inventors: Paul Goldsmith, Hakim Adam Yadi, Andrew John McGlashan Richards, Felicity Kate Sartain, David Cox, David O'Regan